AP
LLY icon

AHL Partners’s Eli Lilly LLY Stock Holding History

AHL Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$3.28M Sell
38,860
-38,020
-49% -$3.23M 0.05% 591
2017
Q3 		$6.58M Buy
76,880
+9,533
+14% +$782K 0.12% 312
2017
Q2 		$5.54M Buy
67,347
+37,725
+127% +$3.08M 0.12% 319
2017
Q1 		$2.49M Buy
29,622
+23,121
+356% +$1.85M 0.05% 573
2016
Q4 		$478K Sell
6,501
-574
-8% -$42.7K 0.01% 852
2016
Q3 		$568K Buy
7,075
+1,336
+23% +$107K 0.02% 795
2016
Q2 		$452K Buy
5,739
+700
+14% +$52.7K 0.02% 633
2016
Q1 		$363K Sell
5,039
-23,334
-82% -$1.77M 0.02% 633
2015
Q4 		$2.39M Buy
28,373
+21,652
+322% +$1.8M 0.19% 201
2015
Q3 		$562K Sell
6,721
-57,220
-89% -$4.83M 0.09% 330
2015
Q2 		$5.34M Sell
63,941
-12,527
-16% -$955K 0.21% 148
2015
Q1 		$5.56M Buy
76,468
+36,766
+93% +$2.62M 0.22% 126
2014
Q4 		$2.74M Buy
39,702
+31,833
+405% +$2.15M 0.14% 284
2014
Q3 		$510K Buy
+7,869
New +$498K 0.04% 482

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AHL Partners's LLY Position: Q4 2017 in Review

AHL Partners reduced its Eli Lilly (LLY) stake by 49% in Q4 2017, selling an estimated $3.23M and leaving 38,860 shares worth $3.28M. The position accounts for 0.05% of the portfolio, ranked #591.

AHL Partners first reported a position in LLY in Q3 2014 and has held it in 14 quarters since. The position peaked at $6.58M in Q3 2017. 1,373 funds tracked by Wall St. Rank hold LLY as of Q4 2017.

  • AHL Partners held 38,860 shares of Eli Lilly worth $3.28M as of Q4 2017.
  • AHL Partners sold 38,020 Eli Lilly shares in Q4 2017, an estimated $3.23M.
  • Eli Lilly made up 0.05% of AHL Partners's portfolio in Q4 2017, its #591 holding.
  • AHL Partners first reported a position in Eli Lilly in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's Eli Lilly position peaked at $6.58M in Q3 2017.
  • 1,373 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.